Introduction {#Sec1}
============

The global rise in the prevalence of obesity, due to adaptation of a Western lifestyle, has resulted in a high incidence of type 2 diabetes (T2DM) with the associated comorbidities and complications, particularly in populations with an increased genetic susceptibility \[[@CR19], [@CR25], [@CR27]\]. Several cardiometabolic risk factors may precede the development of aforementioned conditions, i.e. abdominal obesity, glucometabolic disorders, dyslipidaemia and hypertension. These entities are deemed to share (at least in part) similar pathophysiological backgrounds, since they often cluster within the so-called 'metabolic syndrome' (MetS) \[[@CR29]\]. Although MetS has shown to be predictive for T2DM, especially the glucometabolic derangements impose a high risk to develop T2DM \[[@CR8], [@CR22]\]. Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) seem to differ with respect to their underlying mechanisms, with varying degrees of insulin sensitivity, insulin secretion and hepatic glucose output, as well as glucagon and incretin hormone levels \[[@CR12], [@CR28]\]. Moreover, also differences are found between IFG and IGT as predictors for cardiometabolic outcome measures. Several studies have shown that 2-h glucose and IGT are stronger predictors of cardiometabolic events and mortality as compared to IFG \[[@CR10], [@CR11], [@CR30]\]. Varying rates of prevalence for IFG and IGT are reported among both adult and paediatric populations. The National Health and Nutrition Examination Survey (NHANES) study showed IFG in 26% of the US population ≥ 20 years, while in children (ages 12--19 years), IFG was present in 13.1% (\>5.6 mmol/L) \[[@CR6], [@CR20]\]. In the diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe (DECODE) study (ages 30--90 years), IGT was present in 2.9--24.6%, highly dependent on age group \[[@CR9]\], while the prevalence of IGT in children from the NHANES study was already 3.4% \[[@CR20]\]. Besides the data of the NHANES study, little data have been reported with respect to IFG and especially IGT in non-clinical populations (non-overweight children) due to ethical concerns, and are largely limited to clinical cohorts, i.e. in an obese cohort of 164 children (ages 4--18 year), the prevalence of IGT was 22% \[[@CR33]\]. These studies have also reported associations between prevalence rates and ethnicity. Previously, we found that Turkish children had a more adverse cardiometabolic risk profile than their peers of Moroccan origin, although results regarding differences in IFG versus IGT among ethnic groups remained inconclusive \[[@CR38]\]. It is of importance to know how cardiometabolic risk factors vary per ethnic population to predict or explain differences in cardiometabolic outcomes in adulthood.

Since direct comparisons of glucometabolic derangements among ethnic groups are lacking, we aimed to investigate the prevalence of IFG and IGT according to ethnicity to identify children who might have increased risk for developing T2DM/cardiovascular disease (CVD) and to determine additional associated cardiometabolic risk for IFG and IGT in a large obese multi-ethnic paediatric cohort.

Methods {#Sec2}
=======

Study population and study protocol {#Sec3}
-----------------------------------

Between March 2004 and June 2009, data were collected regarding overweight children (aged 3--18 years) who were referred to the obesity outpatient clinic of either an urban general hospital (Slotervaart Hospital, *n* = 659) or an academic hospital (VU University Medical Centre, *n* = 348) in Amsterdam, the Netherlands. Children were referred to one of the two hospitals by youth health care or general practitioners. Children were excluded from the study when diagnosed with secondary causes of obesity (i.e. hypothyroidism, hypogonadism and pituitary disorders or genetic syndromes), diabetes and/or when they used glucose- or lipid- lowering medication, corticosteroids or drugs acting on the central nervous system. None of the subjects had a history of alcohol abuse, and serologic tests for hepatitis B or C virus were all negative. During the first visit, a detailed history and physical examination was performed, including blood pressure measurements, height, weight and pubertal stage according to Tanner were assessed \[[@CR35]\]. During the second visit, each child underwent an oral glucose tolerance test (OGTT; 1.75 g/kg with a maximum of 75 g). In addition, fasting blood samples were drawn for the assessment of insulin, lipid levels and alanine aminotransferase (ALT), a marker of non-alcoholic fatty liver disease \[[@CR31]\]. Of the aforementioned tests, ALT was only determined in the Slotervaart Hospital (*n* = 659).

Definitions {#Sec4}
-----------

Ethnicity was defined as Dutch if both parents were Dutch native and Moroccan or Turkish in cases where both parents were from that specific country. Children with other ethnicities and children with parents of different origins were collected in a separate group, hereafter referred to as the 'other' group. The 'ethnic minorities' group existed of all children who were not classified as Dutch natives. Body mass index (BMI) was standardized using Z-scores (Z-BMI) according to Dutch reference values \[[@CR14]\].

IGT was defined as a 2-h glucose ≥ 7.8 and \<11.0 mmol/L and IFG was defined as a fasting glucose 5.6 to 6.9 mmol/L \[[@CR41]\]. In case the values exceeded the upper limit of these ranges, diabetes was diagnosed. Insulin resistance was calculated according to the Homeostasis Model Assessment for Insulin Resistance (HOMA-IR): fasting plasma insulin (microunits per litre) × fasting glucose (millimoles per litre)/22.5 \[[@CR23]\]. Insulin resistance was defined as HOMA-IR ≥ 3.5 \[[@CR18]\]. Hyperinsulinaemia was present when fasting plasma insulin was ≥ 90 pmol/L (prepubertal children) and ≥ 180 pmol/L (pubertal children) \[[@CR39]\]. MetS was diagnosed according to a definition for children and adolescents as proposed by Weiss et al. \[[@CR41]\] and was established when obesity (Z-BMI \> 2 corresponding with a BMI ≥ 97th percentile for age and sex) was present, in addition to two or more of the following criteria: a triglyceride level ≥ 95th percentile for age and sex, a high-density lipoprotein (HDL) cholesterol level \<5th percentile for age and sex, a mean (systolic or diastolic) blood pressure value ≥ 95th percentile for height and sex and IGT \[[@CR43]\]. High low-density lipoprotein (LDL) cholesterol was considered present when levels were ≥ 95th percentile for age and sex \[[@CR7]\], and high ALT levels above 30 IU/L \[[@CR17], [@CR37]\].

Biochemical analyses {#Sec5}
--------------------

Plasma glucose levels, total cholesterol, triglycerides and HDL cholesterol were measured by standardized validated methods (SYNCHRON LX20, Beckman Coulter, USA and MODULAR ANALYTICS EVO solution, Roche, Belgium). LDL cholesterol was calculated by the Friedewald formula \[[@CR15]\]. Plasma insulin levels were measured by an immunoluminometric assay (Immulite 200 system, DPC, Los Angeles, USA; intra-assay variation, 3--6%; inter-assay variation, 3--5%) and ADVIA Centaur insulin assay (Siemens, Netherlands; intra-assay variation, 4.6%; inter-assay variation, 6%).

Statistical analyses {#Sec6}
--------------------

Mean (standard deviation, SD) or median (interquartile range, IQR) are shown after stratification for ethnicity. Differences were tested with *χ*^2^ analysis and ANCOVA (with adjustment for sex, ethnicity, pubertal status and Z-BMI). In comparing prevalence rates between groups, logistic regression with adjustment for confounding variables (sex, ethnicity, pubertal status and Z-BMI) was used. Multivariate logistic regression models were used to determine associations of IFG and/or IGT with cardiometabolic risk (using the NGT group as reference group). Results of these analyses are expressed as odds ratios (OR) and 95% confidence intervals (95% CI). Interaction terms were built in order to determine significant interactions by ethnicity in the models. These were considered significant when *P* \< 0.1. In the models, the association of hyperinsulinaemia with IFG and IGT (instead of insulin resistance) was established, since HOMA-IR includes fasting glucose in its formula. A *P* value \< 0.05 was considered statistically significant. All analyses were performed with SPSS, version 15.0 (for Windows).

Results {#Sec7}
=======

Baseline characteristics {#Sec8}
------------------------

Table [1](#Tab1){ref-type="table"} shows the baseline characteristics for children of Dutch origin and children of ethnic origin. The cohort consisted of 1,007 children (mean age 11.4 ± 3.2 years), of whom 50.7% were boys and 46.7% were prepubertal. The main ethnic groups were Dutch native (26.0%), Turkish (23.7%), Moroccan (18.8%) and 'other' (31.5%). The latter group consisted of over 23 ethnicities, with the largest subgroup being Surinamese. Almost all children (94.7%) had a Z-BMI greater then 2 (the reference value of obesity in MetS) \[[@CR43]\]. A total of 16.3% of subjects had IFG, whereas IGT was only present in 4.9% (see Table [1](#Tab1){ref-type="table"}). Fourteen children (1.4%) were detected who fulfilled both IFG and IGT criteria. Table 1Clinical and metabolic characteristics of overweight/obese subjects by ethnicityEntire cohortChildren of Dutch originChildren of ethnic originNumber1,007262745Male (%)50.745.852.5Pubertal (%)58.552.760.5\*Age (years)11.4 ± 3.211.5 ± 3.211.4 ± 3.2Z-BMI2.8 ± 0.52.7 ± 0.62.8 ± 0.5\*Systolic blood pressure (mmHg)116 ± 13116 ± 13116 ± 13Diastolic blood pressure (mmHg)69 ± 967 ± 869 ± 9\*Fasting glucose (mmol/L)5.2 ± 0.45.1 ± 0.45.2 ± 0.4\*Fasting insulin (pmol/L)110 (72--162)110 (67--153)110 (74--167)HOMA-IR3.8 (2.5--5.8)3.9 (2.3--5.6)3.8 (2.5--6.0)Total cholesterol (mmol/L)4.3 ± 0.84.3 ± 0.84.3 ± 0.8HDL cholesterol (mmol/L)1.1 (1.0--1.3)1.2 (1.0--1.3)1.1 (0.9--1.3)\*LDL cholesterol (mmol/L)2.6 ± 0.72.6 ± 0.72.7 ± 0.7Triglycerides (mmol/L)0.8 (0.6--1.2)0.9 (0.6--1.2)0.8 (0.6--1.2)ALT (IU/L)^∞^22 (17--29)22 (17--27)22 (17--29)Prevalence, (%)Z-BMI \> 2 (component of the metabolic syndrome)94.791.296.0The metabolic syndrome15.410.317.2\*IFG16.313.419.2\*IGT4.94.75.3High HDL cholesterol23.312.227.2\*High triglycerides19.518.719.7Hypertension19.316.820.1High ALT^a^11.19.211.5High LDL cholesterol14.316.413.6Insulin resistance54.156.654.8Data are expressed as mean ± SD, *N* (%) and median (interquartile range) for variables with a skewed distribution. *Converting factors*, Millimoles per litre to milligrams per decilitre: glucose, divide by 0.055; HDL/LDL cholesterol, divide by 0.0259; triglycerides, divide by 0.0113. Millimoles per litre to international units per litre: insulin, divide by 6.945. IFG -- impaired fasting glucose, IGT -- impaired glucose intolerance.^∞^*N* = 657\**P* \< 0.05^a^*N* = 657

Relative to prepubertal children, pubertal children had a higher frequency of hypertension (15.8% vs. 5.3%, *P* \< 0.001), low HDL cholesterol levels (50.6% vs. 38.8%, *P* \< 0.001), high triglycerides (10.5% vs. 5.5%, *P* \< 0.01), MetS (25.8% vs. 12.4%, *P* \< 0.001) and insulin resistance (69.7% vs. 34.6%, *P* \< 0.001), regardless of ethnicity.

Prevalence of IFG and IGT according to ethnicity {#Sec9}
------------------------------------------------

Figure [1](#Fig1){ref-type="fig"} presents the prevalence rates of the glucometabolic abnormalities and various cardiometabolic risk factors according to ethnicity. There were no significant differences between Z-BMI between the presented groups. The prevalence of MetS was significantly higher in Turkish children relative to their peers of Moroccan and Dutch native origin. Subsequently, insulin resistance (as determined by HOMA-IR) was least frequently found in Moroccans (as compared to Dutch native and Turkish children, 45.2 vs. 56.6% and 59.7%, both *P* \< 0.05). Fig. 1Prevalence of impaired fasting glucose, impaired glucose tolerance, metabolic syndrome, hypertension, low HDL cholesterol, high triglycerides, high LDL cholesterol, high ALT according to ethnicity; Dutch native (*white bars*), Turkish (*light grey bars*) and Moroccan (*dark grey bars*). (*Asterisk*) *P* \< 0.05, (*infinity*) *N* = 657

Cardiometabolic risk factors according to glucometabolic status {#Sec10}
---------------------------------------------------------------

Figure [2](#Fig2){ref-type="fig"} shows the prevalence of cardiometabolic risk factors stratified for glucometabolic status in the entire cohort. No differences for the association models were observed between different ethnic groups (i.e. interaction terms in the models were not significant) Fig. [2](#Fig2){ref-type="fig"}. Fig. 2Prevalence of the metabolic syndrome, hypertension, low HDL cholesterol, high triglycerides and high ALT according to glucometabolic status; normal glucose tolerance (*white bars*), impaired fasting glucose (*light grey bars*), impaired glucose tolerance (*dark grey bars*) or presence of both (*black bars*). \**P* \< 0.05, ^∞^*N* = 657

Hyperinsulinaemia was present in 29.9% of children with NGT, against 50.6% in IFG children and 50.0% in IGT children (OR, 2.8; 95% CI, 1.9--4.0 for IFG; OR, 1.8; 95% CI, 1.2--2.7 for IGT, respectively). Moreover, the small group with combined IFG and IGT showed 71.4% hyperinsulinaemia (OR of 5.9; 95% CI, 1.8--19.6, as compared to NGT).

Regarding the components of MetS, independent of hyperinsulinaemia, children with IGT more frequently showed hypertension (OR, 2.3; 95% CI, 1.1--4.9), while a trend was seen for high triglycerides (OR, 2.0; 95% CI, 0.9--4.3) as compared to NGT children. In contrast, IFG was associated with HDL cholesterol (IFG vs. NGT; OR, 1.7; 95% CI, 1.2--2.5). Although the group who had both IFG and IGT showed the highest prevalence of components of the MetS, the association was only significant for hypertension (OR, 4.0; 95% CI, 1.4--12.1) as compared to NGT.

Discussion {#Sec11}
==========

In a Dutch multi-ethnic cohort of predominantly obese children, a higher prevalence of IFG (16.3%), rather than IGT (4.9%) was found. IFG was associated with low HDL cholesterol while IGT was associated with hypertension, and a trend was seen towards significance for high triglycerides.

The prevalence of glucometabolic disorders in the present study is higher than recently reported in a study among 535 overweight/obese Italian children, which reported a prevalence of 7.7% for IFG and 3.2% for IGT \[[@CR5]\]. In contrast, other studies among overweight/obese children showed lower prevalence rates for IFG (0.1--0.8%) while showing a higher prevalence for IGT (11.2--25%), relative to our study \[[@CR3], [@CR32], [@CR33]\]. The aforementioned differences may be due to the variation in the Tanner stage of children among the studies \[[@CR32]\] or by different lifestyles (i.e. Turkish and Moroccan people tend to eat more fruits and vegetables and less saturated fat as compared to Dutch natives) \[[@CR4]\]; however, this would mean that Turkish children also would present with a more favourable risk profile. Therefore, it is likely that a great part of the difference is attributable to variation in genetic profile.

Turkish children showed the highest prevalence of IGT and insulin resistance, whereas IFG was most frequently present in Moroccan children who showed the lowest prevalence of insulin resistance. The present study also found differences for other cardiometabolic risk factors among different ethnic groups and was able to show that Turkish children not only have a more adverse cardiometabolic risk profile as compared to Moroccan children, but also relative to Dutch native children.

Epidemiological studies report varying conclusions with respect to cardiometabolic health and ethnic minorities in adults; however, the social health service of Amsterdam confirmed a higher diabetes prevalence among people of Turkish and Moroccan origin (three and fourfold higher), next to higher glucose levels, more unfavourable ratio of total cholesterol, HDL cholesterol, but lower blood pressure values \[[@CR2]\]. Moreover, a higher prevalence of CVD and T2DM among Turkish adults living in the Netherlands was found, in addition to a lower prevalence of CVD (despite a higher prevalence of T2DM at \>45 years) among Moroccan people living in the Netherlands, as compared to the Dutch native population \[[@CR16], [@CR36]\]. We have found that the cardiometabolic disadvantage in people of Turkish origin already starts in childhood, as Turkish children were shown to have a more adverse cardiometabolic risk profile as compared to Moroccan and Dutch native children.

The 'other' group generally showed prevalence rates which were close to the mean prevalence of the entire cohort, which is attributable to the heterogeneity of this group. However, impaired glucose tolerance was relatively often present, which probably results from the relatively high proportion Hindustani children. It is known that Hindustani people more frequently present with diabetes \[[@CR1], [@CR34]\].

Regarding cardiometabolic risk in IFG and IGT, our findings are partly in line with the outcome of the NHANES study, which showed significantly lower mean HDL cholesterol and higher mean systolic blood pressure, fasting plasma insulin and HOMA-IR levels among adolescents with IFG, relative to adolescents with NGT \[[@CR20], [@CR21]\]. In addition, the strong association between IGT and hyperinsulinaemia was also confirmed by the latter study, which showed that insulin resistance played an important role in the pathogenesis of the transition from NGT to IGT \[[@CR33]\]. Conversely, the association of elevated triglycerides and hypertension with IFG could not be established in the present article.

Differences in associations between IFG and IGT and cardiometabolic risk factors may in part be the result of the markedly higher prevalence of high ALT, (a marker of liver steatosis and hepatic insulin resistance), which was found among IGT relative to NGT children and is also associated with components of the metabolic syndrome in children \[[@CR26], [@CR37]\]. Moreover, they might be explained by the proposed differences in pathogenic mechanisms of IFG and IGT. In spite of some common denominators, IFG is more markedly associated with hepatic insulin resistance in the presence of (near) normal muscle insulin sensitivity, whereas IGT has been rather related to impaired muscle insulin sensitivity and normal to slightly reduced hepatic insulin resistance \[[@CR24]\]. Still, both conditions are due to a decrease in acute beta-cell secretory response, as was also established in children \[[@CR42]\]. Consequently, both IFG and IGT confer an increased risk of T2DM \[[@CR40]\].

In the past, a difference between both glucometabolic derangements for cardiometabolic mortality has been reported, underlining the difference in pathophysiology of the two glucometabolic disorders. According to the DECODE study, increasing fasting glucose levels did not predict mortality while increasing 2-h glucose values showed an increase in mortality \[[@CR11]\]. In another study, IFG predicted only overall death from all causes while IGT was predictive for death from all causes, in addition to CVD and coronary heart disease \[[@CR11]\]. Moreover, it was concluded that only subjects who converted from IFG to T2DM had a higher risk of CVD mortality \[[@CR30]\]. Until there is a definite answer to the question how glucometabolic disorders affect cardiometabolic risks and which role each glucometabolic disorder fulfills in the development of T2DM, one can only speculate with regard to the meaning of the finding of an unusual high prevalence of IFG in the present cohort. In addition, little information is available regarding the actual increased cardiometabolic risk of paediatric obesity; however, in a recent study among a large cohort of American Indian children, with a follow-up of 24 years, obesity, glucose intolerance and hypertension in childhood were strongly associated with increased rates of premature death from endogenous causes while hypercholesterolaemia was not identified as a major predictor \[[@CR13]\].

This study has several limitations. First, due to the cross-sectional design causal inferences between glucometabolic disorders, cardiovascular risk factors and ethnicity cannot be made. Moreover, due to lack of power, no significant associations between the presence of both IFG and IGT with cardiometabolic risk factors could be confirmed. In summary, in this retrospective study we found that glucometabolic disorders, in particular IFG more than IGT, are highly prevalent in overweight and obese Dutch children and adolescents of multi-ethnic origin. Turkish children showed the most adverse cardiometabolic risk profile, as compared to Dutch native and Moroccan children, which suggests an ethnic-specific difference in T2DM and CVD risk. IFG and IGT did not share similar associations with other components of MetS. Studies are warranted which investigate the long-term outcome of the presence of glucometabolic disorders in childhood on actual cardiometabolic risk concerning different ethnic paediatric populations.
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